Comparison of self-sampling blood collection for N-glycosylation analysis
Cvetko et al.
The finding, in our words
Neoteryx Mitra sticks and Noviplex cards agreed more closely with venous plasma and gave more repeatable N-glycoprofiling results than dried blood spots, with relative deviance from plasma of 0.092 and 0.069 respectively compared with 0.674 for dried blood spots, and coefficient of variation values of 7.098 per cent and 4.831 per cent against 14.305 per cent for dried blood spots. The findings support these self-sampling devices for decentralised glycoanalysis, though the authors call for larger cohort validation.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
Capillary C-peptide concentrations measured from dried blood spot and volumetric absorptive microsampling showed strong agreement with reference plasma samples. Both sampling methods maintained stability over 48 hours at room temperature, supporting their utility for remote monitoring of endogenous insulin secretion.
Capillary samples collected using dried blood spots and Mitra microsamplers showed strong agreement with venous plasma for quantifying IgG antibodies against most vaccine-preventable diseases. Sensitivity was high for the majority of pathogens, though the study noted that antibody stability declined at room temperature over time, favouring cold storage for longer durations.
In matched clinical samples from rheumatoid arthritis, VAMS and DBS showed strong agreement for methotrexate polyglutamates (slopes 0.95-1.07; bias within -4.21% to 0.36%; SRCC ≥ 0.969), with up to 100% of total MTXPG results within ±20% limits; capillary microsampling agreed closely with whole blood but differed from red blood cells, indicating matrix-specific differences that must be accounted for when interpreting against RBC-based reference values.
This study validated a method for measuring the alcohol biomarker phosphatidylethanol using two volumetric absorptive microsampling devices, finding that the Mitra device met all validation criteria and agreed with venous sampling. The Capitainer device was deemed suitable but showed reduced accuracy at higher concentrations, with a small proportional negative bias compared to venous results.
A comparison of three patient-centric dried blood microsampling devices, paper DBS, Mitra and Tasso-M20, found strong to excellent correlation with traditional venous plasma for measuring branched-chain amino acids and ketoacids. Participants reported high acceptability and expressed a strong willingness to use these devices for decentralised self-collection.